Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (84)

2024

  1. Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study

    Diabetes Research and Clinical Practice, Vol. 207

  2. Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study

    Atherosclerosis, Vol. 393

  3. Machine Learning Model in Obesity to Predict Weight Loss One Year after Bariatric Surgery: A Pilot Study

    Biomedicines, Vol. 12, Núm. 6

  4. Minimally invasive techniques for the management of benign thyroid nodules: Efficacy and impact on quality of life of percutaneous ethanol injection. Results from a high-resolution thyroid nodule unit

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 9, pp. 380-389

  5. New Perspectives for Low Muscle Mass Quantity/Quality Assessment in Probable Sarcopenic Older Adults: An Exploratory Analysis Study

    Nutrients, Vol. 16, Núm. 10

2023

  1. Low Muscle Mass Is Associated with Poorer Glycemic Control and Higher Oxidative Stress in Older Patients with Type 2 Diabetes

    Nutrients, Vol. 15, Núm. 14

  2. Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

    Diabetes Therapy, Vol. 14, Núm. 4, pp. 723-736

2022

  1. A Very Rare Variant in SREBF2, a Possible Cause of Hypercholesterolemia and Increased Glycemic Levels

    Biomedicines, Vol. 10, Núm. 5

  2. Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity

    Microvascular Research, Vol. 139

  3. Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players

    Biomedicine and Pharmacotherapy, Vol. 145

  4. Corticotroph cell hyperplasia as a rare cause of ACTH-dependent Cushing syndrome

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 694-701

  5. DECREASED URINARY LEVELS OF SIRT1 AS NON-INVASIVE BIOMARKER OF EARLY RENAL DAMAGE IN HYPERTENSION

    Journal of hypertension, Vol. 40, pp. e249

  6. Developing a simple and practical decision model to predict the risk of incident type 2 diabetes among the general population: The Di@bet.es Study

    European Journal of Internal Medicine, Vol. 102, pp. 80-87

  7. Effect of personality on blood glucose control in patients with type 1 diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 677-685

  8. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO)

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 540-542

2021

  1. Anthropometric Indicators as a Tool for Diagnosis of Obesity and Other Health Risk Factors: A Literature Review

    Frontiers in Psychology, Vol. 12

  2. Frailty is associated with oxidative stress in older patients with type 2 diabetes

    Nutrients, Vol. 13, Núm. 11

  3. Hypercholesterolemic patients have higher eryptosis and erythrocyte adhesion to human endothelium independently of statin therapy

    International Journal of Clinical Practice, Vol. 75, Núm. 11

  4. Hypotriglyceridemias/hypolipidemias

    Clinica e Investigacion en Arteriosclerosis, Vol. 33, pp. 63-68

  5. Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients

    Frontiers in Pharmacology, Vol. 12